Background We reviewed our experience with 505 patients with confirmed coronavirus
disease-2019 (COVID-19) supported with extracorporeal membrane oxygenation (ECMO) at …

Objective: To estimate the global risk and risk factors associated with acute respiratory
distress syndrome (ARDS) among patients with COVID-19: Design: A systematic review …

Background COVID-19 patients requiring mechanical ventilation are particularly at risk of
developing ventilator-associated pneumonia (VAP). Risk factors and the prognostic impact …

Background Extracorporeal membrane oxygenation (ECMO) is a potential option for the
management of severe acute respiratory failure secondary to COVID-19. Conflicting the use …

Extracorporeal membrane oxygenation (ECMO) represents a viable therapy option for
patients with refractory acute respiratory distress syndrome (ARDS). Currently, veno-venous …

Background The COVID-19 pandemic has led to a boom in the use of VV ECMO for ARDS
secondary to COVID. Comparisons of outcomes of ECMO for COVID to ECMO for influenza …

Objective Myocardial damage occurs in up to 25% of coronavirus disease 2019 (COVID‐19)
cases. While veno‐venous extracorporeal life support (V‐V ECLS) is used as respiratory …

Background Coronavirus disease 2019 (COVID-19) infection is associated with significant
morbidity and mortality. Some patients develop severe acute respiratory distress syndrome …

Objectives We reviewed 594 consecutive patients with Coronavirus Disease 2019
supported with extracorporeal membrane oxygenation at 49 hospitals within 21 states and …

Introduction Although extracorporeal membrane oxygenation (ECMO) has been associated
with improved outcomes in COVID patients with respiratory failure, data regarding the need …